lutetium and Lymphoma
lutetium has been researched along with Lymphoma in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Azorín-Vega, E; Ferro-Flores, G; Jiménez-Mancilla, N; Martínez-Ventura, B; Ordaz-Rosado, D; Ramos-Bernal, J; Rojas-Calderón, E; Serrano-Espinoza, L | 1 |
| Bäck, TA; Booth, GC; Fisher, DR; Frayo, SL; Frost, SH; Gopal, AK; Green, DJ; Hylarides, MD; Lin, Y; Miller, BW; Orozco, JJ; Pagel, JM; Press, OW | 1 |
| Banerjee, S; Das, T; Mishra, KP; Sarma, HD; Venkatesh, M; Vidyasagar, PB | 1 |
| Boerman, OC; Corstens, FH; Frielink, C; Goldenberg, DM; Oyen, WJ; Postema, EJ; Raemaekers, JM | 1 |
| Anderson, TL; Arterburn, JB; Erion, J; Larson, RS; Norenberg, JP; Poria, RB; Wagner, CR | 1 |
Other Studies
5 other study(ies) available for lutetium and Lymphoma
| Article | Year |
|---|---|
Assessment of cell death mechanisms triggered by
Topics: Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Radiation; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Humans; Immunoconjugates; Lutetium; Lymphoma; Radioimmunotherapy; Radioisotopes; Rituximab | 2018 |
Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.
Topics: Animals; Antigens, CD20; Beta Particles; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Humans; Immunoconjugates; Lutetium; Lymphoma; Mice; Mice, Nude; Radioimmunotherapy; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2015 |
Studies on efficacy of a novel 177Lu-labeled porphyrin derivative in regression of tumors in mouse model.
Topics: Animals; Female; Fibrosarcoma; Lutetium; Lymphoma; Mice; Neoplasms, Experimental; Porphyrins; Radioisotopes; Radiopharmaceuticals; Thymus Neoplasms; Tissue Distribution | 2011 |
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Cell Adhesion Molecules; Duodenum; Female; Femur; Humans; Iodine Radioisotopes; Kidney; Lectins; Liver; Lung; Lutetium; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Nude; Muscles; Neoplasm Transplantation; Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Sialic Acid Binding Ig-like Lectin 2; Spleen; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2003 |
Characterization of a radiolabeled small molecule targeting leukocyte function-associated antigen-1 expression in lymphoma and leukemia.
Topics: Animals; Binding, Competitive; Heterocyclic Compounds, 1-Ring; HL-60 Cells; Humans; Hydantoins; Imidazolidines; Isotope Labeling; Kinetics; Leukemia; Lutetium; Lymphocyte Function-Associated Antigen-1; Lymphoma; Mice; Molecular Structure; Organometallic Compounds; Radioisotopes; Radionuclide Imaging | 2006 |